SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K


CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934


Date of Report (Date of earliest event reported): July 31, 2008

Natus Medical Incorporated

(Exact name of registrant as specified in its charter)

 

 

 
 

Delaware

000-33001

77-0154833

(State or other jurisdiction

of Incorporation)

(Commission
File Number)

(IRS Employer

Identification No.)

1501 Industrial Road San Carlos, California 94070

(Address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code:

(650) 802-0400

 

Not applicable

(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



Item 2.02     Results of Operations and Financial Condition.

On July 31, 2008, Natus Medical Incorporated (the “Company”) is issuing a press release and holding a conference call regarding its financial results for the second fiscal quarter of 2008 ended June 30, 2008 and other financial information.  A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K.

The information in this Form 8-K and the exhibit attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.


Item 9.01     Financial Statements and Exhibits.

  (d) Exhibits.
 

Exhibit No.

Description

 
99.1 Press release of Natus Medical Incorporated dated July 31, 2008 describing the Company’s results for its second fiscal quarter ended June 30, 2008 and other financial information.



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

NATUS MEDICAL INCORPORATED

 

 

 

Date:

July 31, 2008

By:

/s/ Steven J. Murphy

Steven J. Murphy

Vice President Finance and Chief Financial Officer


Index to Exhibits

  Exhibit No. Description
 
99.1 Press release of Natus Medical Incorporated dated July 31, 2008 describing the Company’s results for its second fiscal quarter ended June 30, 2008 and other financial information.